where was glp 1 discovered Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions Glucagon-like peptide-1 - Wikipedia

The FDA removed semaglutide from the drug shortage list in February 2025 and tirzepatide in October 2024, which restricted 503B outsourcing facilities from large-scale compounding

Medicaid spending Medicaid programs cover some GLP-1 drugs to treat obesity in at least 13 other states: California, Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, New Hampshire, Pennsylvania, Rhode Island, South Carolina, Virginia and Wisconsin

This lawsuit was filed against Novo Nordisk, the pharmaceutical company behind Ozempic, seeking compensation for an individual who suffered severe medical consequences

Melanotan Side Effects and Safety Melanotan peptides appear to have a good safety profile

Severe nausea with vomiting requires immediate attention